Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
This program has been made available online.
In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.
Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)
Dr. Jens D. Lundgren reviews diagnostic tests for SARS-CoV-2 infection, contrasting antigen tests with nucleic acid assays, and describing how to use and interpret antigen tests from Clinical Care Options (CCO)
Dr. Arthur Kim reviews EUAs for baricitinib, bamlanivimab, and casirivimab/imdevimab, and NIH Guideline on ivermectin from Clinical Care Options (CCO)